52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Baxter International Inc Entered Into A New Term Loan Credit Agreement
Baxter Announces U.S. FDA Approval And Launch Of Ready-To-Use Cardiovascular Medicine Norepinephrine In Premix Formulation
Baxter Issues Urgent Medical Device Correction To Reinforce Safety Information For Dose IQ Safety Software Desktop Application V.9.0X
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.
Medical Equipment & Supplies
1 Baxter Pkwy
Jose E. Almeida
Chairman of the Board, President, Chief Executive Officer
James K. Saccaro
Chief Financial Officer, Executive Vice President
Sean B. W. Martin
Senior Vice President, General Counsel
Jeanne K. Mason
Senior Vice President - Human Resources
Senior Vice President, President - America
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Sullivan & Cromwell and Wachtell, Lipton, Rosen & Katz are crafting medical technology company Baxter International Inc’s plans to purchase competitor Hill-Rom Holdings Inc for roughly $10.5 billion in cash.
U.S. medtech firm Baxter International Inc said on Thursday it would buy rival Hill-Rom Holdings Inc for about $10.5 billion, adding smart hospital beds to its portfolio of patient monitoring and diagnostic products.
U.S. medtech firm Baxter International Inc said on Thursday it would buy rival Hill-Rom Holdings Inc for roughly $10.5 billion, adding smart hospital beds to its portfolio of patient monitoring and diagnostic products. (Reporting by Dania Nadeem in Bengaluru; Editing by...
U.S.-based medical technology company Baxter International Inc is nearing a deal to buy medical equipment maker Hill-Rom Holdings Inc for more than $10 billion, a person familiar with the matter said on Monday.
U.S.-based medical technology company Baxter International Inc is in advanced talks to buy medical equipment maker Hill-Rom Holdings Inc for about $10 billion, the Wall Street Journal reported on Sunday, citing people familiar with the matter.
Drugmaker Baxter International Inc will help fill in vials and package about 60-90 million doses of Moderna Inc's COVID-19 vaccine in 2021, the companies said on Monday.
Baxter International Inc will provide fill and finish sterile production services for about 60-90 million doses of Moderna Inc's COVID-19 vaccine in 2021, the companies said on Monday. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)
A Chicago federal judge dismissed a proposed class action against Baxter International Inc on Tuesday, writing that shareholders failed to claim the medical equipment company and its top executives knew the company was not accurately recording foreign transactions.
Medical supplies provider Baxter International Inc has approached medication management software vendor Omnicell Inc with an offer to acquire it for more than $5 billion, people familiar with the matter said on Tuesday.
* BAXTER ANNOUNCES U.S. FDA CLEARANCE OF ALTAPORE SHAPE BIOACTIVE BONE GRAFT FOR USE IN SURGERY Source text for Eikon: Further company coverage:
* BAXTER HIGHLIGHTS NEW DATA ON THE ROLE TECHNOLOGIES PLAY IN IMPROVING CARE FOR DIALYSIS PATIENTS DURING THE 57TH ERA-EDTA VIRTUAL CONGRESS
Mexican President Andres Manuel Lopez Obrador on Wednesday ordered an investigation into allegations the former government irregularly awarded lucrative contracts to a firm allegedly tied to the family of his predecessor, Enrique Pena Nieto.
* BAXTER RECEIVES CE MARKING AND AUSTRALIAN REGULATORY APPROVAL FOR EVO IQ SYRINGE INFUSION SYSTEM, BUILDING ON SMART PUMP PLATFORM Source text for Eikon: Further company coverage:
* BAXTER ANNOUNCES RESULTS OF CLINICAL TRIAL ON BENEFITS OF DYNAMIC FLUID MANAGEMENT IN SEPTIC SHOCK PATIENTS
* Q1 REVENUE $2.8 BILLION VERSUS REFINITIV IBES ESTIMATE OF $2.75 BILLION
* BAXTER - IN 2020, AUDIT COMMITTEE TO CONTINUE TO ACTIVELY OVERSEE REMEDIAL ACTIONS TO HELP ENSURE THAT EVENTS LEADING TO RESTATEMENT DO NOT RECUR
Baxter International Inc <BAX.N> said on Wednesday it would hire up to 2,000 employees globally, including 800 people in the United States, in response to higher demand for its medical devices due to rise in cases of the new coronavirus infections.
* BAXTER INTERNATIONAL INC - HIRING UP TO 2,000 NEW EMPLOYEES GLOBALLY
A federal judge has dismissed a proposed class action accusing Baxter International and Pfizer Inc's Hospira of engaging in an anticompetitive scheme to restrict the output of intravenous saline solutions in order to boost prices.
* BAXTER TO HOST ITS ANNUAL MEETING OF STOCKHOLDERS IN VIRTUAL FORMAT Source text for Eikon: Further company coverage:
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.